Anti-Amyloid Therapies for Alzheimer’s Disease: An Alzheimer Europe Position Paper and Call to Action
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Anti-Amyloid Therapies for Alzheimer’s Disease: An Alzheimer Europe Position Paper and Call to Action ; volume:11 ; number:2 ; day:10 ; month:2 ; year:2024 ; pages:265-273 ; date:3.2024
The journal of prevention of Alzheimer's disease ; 11, Heft 2 (10.2.2024), 265-273, 3.2024
- Urheber
-
Bradshaw, Angela C.
Georges, J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2024.37
- URN
-
urn:nbn:de:101:1-2404260705308.590404085829
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bradshaw, Angela C.
- Georges, J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Alzheimer’s disease hypothesis and related therapies
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Amyloid PET imaging: applications beyond Alzheimer’s disease
Non-drug Therapies for Alzheimer’s Disease: A Review
The Development of Pharmacological Therapies for Alzheimer’s Disease
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer’s Disease in Japan
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Alzheimer’s disease hypothesis and related therapies
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Amyloid PET imaging: applications beyond Alzheimer’s disease
Non-drug Therapies for Alzheimer’s Disease: A Review
The Development of Pharmacological Therapies for Alzheimer’s Disease
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer’s Disease in Japan
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Alzheimer’s disease hypothesis and related therapies
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Amyloid PET imaging: applications beyond Alzheimer’s disease
Non-drug Therapies for Alzheimer’s Disease: A Review
The Development of Pharmacological Therapies for Alzheimer’s Disease
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer’s Disease in Japan
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease